AUY922 Terminated Phase 2 Trials for Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01485536A Study of the HSP90 Inhibitor AUY922